Sustained response to brigatinib in a patient with refractory metastatic pheochromocytoma harboring R1192P anaplastic lymphoma kinase mutation: a case report from the Austrian Group Medical Tumor Therapy next-generation sequencing registry and discussion of the literature
暂无分享,去创建一个
R. Greil | F. Huemer | T. Melchardt | G. Rinnerthaler | D. Kotzot | G. Hutarew | R. Heregger | S. Hecht | L. Weiss | E. Schamschula | L. Cheveresan